The impact of delay in time to surgical treatment of Merkel cell carcinoma on overall survival and disease specific survival: a population-based analysis

Published: 28 July 2021| Version 1 | DOI: 10.17632/zc2scv8sxy.1


The aim of our study is to determine whether delays between diagnosis and surgical treatment of Merkel Cell Carcinoma (MCC) are associated with changes in overall survival (OS) and disease-specific survival (DSS). Using the Surveillance, Epidemiology, and End Results Program (SEER) database, our data does not show that delays are associated with worse OS or DSS.